Inovio Pharmaceuticals, Inc. INO

1.18 (0.03) (2.48%) as of 25 Sep
Market cap
$126.9M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
1.00 1.04 1.40 0.79
Net Debt/EBITDA
2.05 1.78 3.49 2.49
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.22) (0.31) (0.42) (0.41)
Book value per Share
0.05 0.09 0.51 (0.15)
Free Cash Flow
(18.05) (21.59) (19.50) (21.64)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates